Vir licensing deal; Cytokinetics wins China nod; Vistagen's social anxiety fail
Vir licensing deal; Cytokinetics wins China nod; Vistagen's social anxiety fail
Vir licensing deal; Cytokinetics wins China nod; Vistagen's social anxiety fail
A compact weekly email covering company moves, product signals, regulatory updates, and notable funding.